1. P.07.13 SAFETY AND EFFICACY OF INFLIXIMAB BIOSIMILAR SB2 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WHO UNDERWENT A SWITCH FROM INFLIXIMAB BIOSIMILAR CT-P13. (25th March 2019) Authors: Lovero, R.; Losurdo, G.; Biscaglia, G.; Valvano, M.R.; Biancofiore, A.; Martino, G.; Nardella, M.; Andriulli, A.; Principi, M.; Bossa, F. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗